Jump to content

Advanced prostate cancer drug Zytiga (abiraterone) tied up in red tape


Recommended Posts

Zytiga (also known as abiraterone) is a drug used to treat prostate cancer. Not only does it extend life for many men, it gives a much higher quality of life than other treatments. It is approved, and supplied at no cost, in the USA for men either before, or after harsher chemotherapies. In Australia it is approved only after the harsher chemotherapy Taxotere (docetaxel). However, despite the recommendation of an expert committee, it still awaits Cabinet approval to place it in the Pharmaceutical Benefits Scheme (PBS) where it would be available at little or no cost for all Australian men who need it.


The following article was published in the Sun Herald and The Age, and also online at the Brisbane Times, Canberra Times and WA Today.



The link below is to a page or document that we do not control. 
Parts of it may be wrong or misleading. 
Check with your doctor if something interests you. 
If it is temporarily or permanently unavailable, you may receive an error message.


Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...